908 Devices Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

908 Devices hat ein Gesamteigenkapital von $156.9M und eine Gesamtverschuldung von $0.0, was einen Verschuldungsgrad von 0% ergibt. Die Gesamtaktiva und Gesamtpassiva betragen $189.8M bzw. $32.9M.

Wichtige Informationen

Verhältnis von Schulden zu Eigenkapital

US$0

Verschuldung

Zinsdeckungsgrad	n/a
Bargeld	US$77.38m
Eigenkapital	US$156.36m
Gesamtverbindlichkeiten	US$52.42m
Gesamtvermögen	US$208.77m

Jüngste Berichte zur Finanzlage

We Think 908 Devices (NASDAQ:MASS) Can Afford To Drive Business Growth

Mar 30

Recent updates

908 Devices: Key Investor Now Selling

Sep 08

Why We're Not Concerned Yet About 908 Devices Inc.'s (NASDAQ:MASS) 29% Share Price Plunge

Aug 16

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: MASSDie kurzfristigen Aktiva des Unternehmens ($161.9M) übersteigen seine kurzfristigen Passiva ($19.3M).

Langfristige Verbindlichkeiten: MASSDie kurzfristigen Vermögenswerte des Unternehmens ($161.9M) übersteigen seine langfristigen Verbindlichkeiten ($13.6M).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: MASS ist schuldenfrei.

Schulden abbauen: MASS hat keine Schulden im Vergleich zu vor 5 Jahren, als das Verhältnis von Schulden zu Eigenkapital 205.1% betrug.

Bilanz

Liquiditätsreserve-Analyse

Bei Unternehmen, die in der Vergangenheit im Durchschnitt Verluste gemacht haben, wird geprüft, ob sie über einen Liquiditätsvorlauf von mindestens einem Jahr verfügen.

Stabile Start- und Landebahn für Bargeld: MASS auf der Grundlage seines derzeitigen freier Cashflows über eine ausreichende Liquiditätsreserve für mehr als ein Jahr verfügt.

Vorhersage Cash Runway: MASS über eine ausreichende Liquiditätsreserve für mehr als 3 Jahre verfügt, wenn der freie Cashflow weiterhin mit historischen Raten von 34.7 % pro Jahr zurückgeht

908 Devices Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

We Think 908 Devices (NASDAQ:MASS) Can Afford To Drive Business Growth

Recent updates

908 Devices: Key Investor Now Selling

Why We're Not Concerned Yet About 908 Devices Inc.'s (NASDAQ:MASS) 29% Share Price Plunge

908 Devices Inc. Maintains Revenue Guidance for the Full Year 2024

908 Devices Inc. to Report Q2, 2024 Results on Aug 06, 2024

908 Devices Appoints Michele M. Leonhart to Board of Directors

908 Devices Enhances Xplorir Portable Analyzer to Simultaneously Identify and Quantify Hazardous Gases and Vapors

Co-Founder recently bought US$56k worth of stock

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

908 Devices Inc., Annual General Meeting, Jun 13, 2024

908 Devices Inc. (NasdaqGM:MASS) acquired CAM2 Technologies, LLC for $76.6 million.

908 Devices Inc. to Report Q1, 2024 Results on Apr 30, 2024

Co-Founder exercised options to buy US$263k worth of stock.

We Think 908 Devices (NASDAQ:MASS) Can Afford To Drive Business Growth

New major risk - Revenue and earnings growth

Full year 2023 earnings: EPS exceeds analyst expectations

908 Devices Inc. Provides Earnings Guidance for the Full Year 2024

908 Devices Inc. to Report Q4, 2023 Results on Mar 05, 2024

CFO & Treasurer exercised options and sold US$109k worth of stock

CFO & Treasurer notifies of intention to sell stock

Co-Founder notifies of intention to sell stock

Investors Appear Satisfied With 908 Devices Inc.'s (NASDAQ:MASS) Prospects

908 Devices Inc. Announces MX908 Integration Capabilities

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

908 Devices Inc. Provides Earnings Guidance for the Full Year 2023

New major risk - Revenue and earnings growth

908 Devices Inc. to Report Q3, 2023 Results on Nov 07, 2023

908 Devices Launches Maverick for Real-Time In-Line Monitoring of Multiple Bioprocess Parameters

New minor risk - Shareholder dilution

908 Devices Inc. Updates Revenue Guidance for the Year 2023

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

908 Devices Inc Announces the Launch of MX908 Beacon

908 Devices Inc. to Report Q2, 2023 Results on Aug 08, 2023

Co-Founder notifies of intention to sell stock

Co-Founder notifies of intention to sell stock

908 Devices Inc. Provides Revenue Guidance for Full Year 2023

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

908 Devices Inc. Launches Data Analysis Visualization Tool for REBEL at-Line Cell Culture Media Analyzer

Co-Founder notifies of intention to sell stock

Consensus EPS estimates fall by 22%

Full year 2022 earnings: EPS misses analyst expectations

908 Devices Inc. to Report Q4, 2022 Results on Mar 07, 2023

Co-Founder notifies of intention to sell stock

Co-Founder notifies of intention to sell stock

908 Devices Inc. Announces the Launch of Maven

Co-Founder notifies of intention to sell stock

Consensus revenue estimates fall by 12%

Co-Founder notifies of intention to sell stock

Third quarter 2022 earnings: EPS exceeds analyst expectations

908 Devices Inc. Updates Its Revenue Guidance for Full Year 2022

908 Devices Inc. Launches Pesticide Identification Capability to Thwart Illegal Marijuana Growing Operations

908 Devices Inc. to Report Q3, 2022 Results on Nov 14, 2022

Co-Founder notifies of intention to sell stock

Co-Founder notifies of intention to sell stock

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

908 Devices Inc. (NasdaqGM:MASS) acquired TRACE Analytics GmbH for $17.3 million,

908 Devices Q2 2022 Earnings Preview

VP, Secretary & General Counsel exercised options and sold US$161k worth of stock

908 Devices Inc. to Report Q2, 2022 Results on Aug 09, 2022

CFO & Treasurer exercised options and sold US$168k worth of stock

908 Devices Inc. Provides Earnings Guidance for the Full Year 2022

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

908 Devices Inc. Advances MX908 Handheld Device Capabilities

Price target decreased to US$33.00

908 Devices Inc., Annual General Meeting, Jun 16, 2022

Vice President of Corporate Development exercised options and sold US$270k worth of stock

908 Devices Inc. to Report Q1, 2022 Results on May 10, 2022

Nicolas Barthelemy Announces Decision Not to Stand for Re-Election as Member of the Board of 908 Devices Inc

Co-Founder notifies of intention to sell stock

908 Devices Inc. Provides Revenue Guidance for the Year 2022

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

908 Devices Inc. Appoints Tony J. Hunt to Its Board of Directors

Vice President of Corporate Development exercised options and sold US$201k worth of stock

908 Devices Inc. to Report Q4, 2021 Results on Mar 07, 2022

908 Devices Aims For Broadened Footprint